Literature DB >> 21367814

Polymorphisms of the TIM-1 and TIM-3 genes are not associated with systemic lupus erythematosus in a Chinese population.

Wen-Xian Li1, Gui-Mei Chen, Hui Yuan, Ying-Shui Yao, Ruo-Jie Li, Hai-Feng Pan, Xiang-Pei Li, Jian-Hua Xu, Jin-Hui Tao, Dong-Qing Ye.   

Abstract

Systemic lupus erythematosus (SLE) is a prototypic systemic autoimmune diseases, which affects multiple organ systems such as kidney. The imbalance of T-helper 1 (Th1)/Th2 cells is critical in the pathogenesis of SLE. The T-cell immunoglobulin mucin (TIM) proteins comprise a family of cell surface molecules expressed on T cells that regulate Th1- and Th2-cell-mediated immunity. Recent work has found increased expression of TIM-1 and TIM-3 ligand (galactin-9) mRNA in SLE patients and implied that TIM proteins might be involved in the pathogenesis of SLE. In this study, genotyping of single-nucleotide polymorphisms (SNPs) was performed for TIM-1 (rs1501909 and rs12522248) and TIM-3 (rs9313439 and rs10515746) in 202 SLE patients and 217 healthy individuals in a Chinese population. Results showed no significant differences existed between the patients with SLE and the controls as well as SLE patients with nephritis and those without nephritis, in all four SNPs. The findings suggest that the polymorphisms of TIM gene family might not contribute to SLE susceptibility in the Chinese population. However, it should be noted that the statistical power of our study is relatively low, which likely did not have adequate power to detect the actual correlation between the selected SNPs and SLE susceptibility; moreover, we cannot discard a possible association of other variants within the region covering TIM with SLE as a genetic risk factor, with larger samples in different populations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21367814     DOI: 10.1093/mutage/ger009

Source DB:  PubMed          Journal:  Mutagenesis        ISSN: 0267-8357            Impact factor:   3.000


  9 in total

1.  Expression of human T cell immunoglobulin domain and mucin-3 on kidney tissue from immunoglobulin A nephropathy patients.

Authors:  Xiangdong Yang; Zhao Hu; Xiyan Xia; Junhui Zhen; Xuewei Zhuang; Tao Peng
Journal:  Immunol Res       Date:  2014-10       Impact factor: 2.829

Review 2.  TIM polymorphisms--genetics and function.

Authors:  J Lee; B Phong; A M Egloff; L P Kane
Journal:  Genes Immun       Date:  2011-11-03       Impact factor: 2.676

3.  Expression of human T cell immunoglobulin domain and mucin-3 (TIM-3) on kidney tissue from systemic lupus erythematosus (SLE) patients.

Authors:  Ling Guo; Xiangdong Yang; Qing Xia; Junhui Zhen; Xuewei Zhuang; Tao Peng
Journal:  Clin Exp Med       Date:  2013-11-20       Impact factor: 3.984

4.  Distinct role of Tim-3 in systemic lupus erythematosus and clear cell renal cell carcinoma.

Authors:  Hongying Zheng; Xingqing Guo; Qingwu Tian; Hui Li; Yuanqi Zhu
Journal:  Int J Clin Exp Med       Date:  2015-05-15

5.  TIM-3 Rs10515746 (A/C) and Rs10053538 (C/A) Gene Polymorphisms and Risk of Multiple Sclerosis.

Authors:  Esmat Yaghoobi; Saeed Abedian; Omid Babani; Maryam Izad
Journal:  Iran J Public Health       Date:  2016-05       Impact factor: 1.429

6.  TIM-3 genetic variants and risk of Behçet disease in the Iranian population.

Authors:  Mitra Ataei; Farinaz Behfarjam; Zohreh Jadali
Journal:  An Bras Dermatol       Date:  2019-10-17       Impact factor: 1.896

7.  Genetic polymorphisms of rs9313422 G>C and rs41297579 G>A at the promoter of TIM-1 gene contribute to the risk of community-acquired pneumonia in children.

Authors:  Yang Liu; Hong-Bo Xu
Journal:  J Clin Lab Anal       Date:  2019-12-04       Impact factor: 2.352

8.  Tim-1 alleviates lupus nephritis-induced podocyte injury via regulating autophagy.

Authors:  Yunxia Yu; Caixia Zhu; Nan Yu; Lijuan Yang
Journal:  Cent Eur J Immunol       Date:  2021-10-19       Impact factor: 2.085

9.  TIM-3 rs1036199 polymorphism increases susceptibility to autoimmune diseases: evidence based on 4200 subjects.

Authors:  Rongzeng Liu; Xing Wang; Xiafei Chen; Shengnan Wang; Heqian Zhang
Journal:  Biosci Rep       Date:  2018-11-23       Impact factor: 3.840

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.